-
1
-
-
0036186813
-
The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society
-
Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78
-
(2002)
Neurourol Urodyn
, vol.21
, pp. 167-178
-
-
Abrams, P.1
Cardozo, L.2
Fall, M.3
-
2
-
-
0035725404
-
How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study
-
Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760-6
-
(2001)
BJU Int
, vol.87
, pp. 760-766
-
-
Milsom, I.1
Abrams, P.2
Cardozo, L.3
Roberts, R.G.4
Thuroff, J.5
Wein, A.J.6
-
3
-
-
0141566431
-
Prevalence and burden of overactive bladder in the United States
-
Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-36
-
(2003)
World J Urol
, vol.20
, pp. 327-336
-
-
Stewart, W.F.1
Van Rooyen, J.B.2
Cundiff, G.W.3
-
4
-
-
0036930323
-
Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder
-
Kelleher CJ, Kreder KJ, Pleil AM, Burgess SM, Reese PR. Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 2002; 8 (Suppl. 19): S616-30
-
(2002)
Am J Manag Care
, vol.8
, Issue.19 SUPPL.
-
-
Kelleher, C.J.1
Kreder, K.J.2
Pleil, A.M.3
Burgess, S.M.4
Reese, P.R.5
-
6
-
-
0000713128
-
After a decade of intravesical vanilloid therapy: Still more questions than answers
-
Szallasi A, Fowler CJ. After a decade of intravesical vanilloid therapy: still more questions than answers. Lancet Neurol 2002; 1: 167-72
-
(2002)
Lancet Neurol
, vol.1
, pp. 167-172
-
-
Szallasi, A.1
Fowler, C.J.2
-
7
-
-
1542298215
-
Mechanisms involved in new therapies for overactive bladder
-
Cruz F. Mechanisms involved in new therapies for overactive bladder. Urology 2004; 63 (Suppl. 3): 65-73
-
(2004)
Urology
, vol.63
, Issue.3 SUPPL.
, pp. 65-73
-
-
Cruz, F.1
-
8
-
-
0029075577
-
Long-lasting desensitization of bladder afferents following intravesical resiniferatoxin and capsaicin in the rat
-
Craft RM, Cohen SM, Porreca F. Long-lasting desensitization of bladder afferents following intravesical resiniferatoxin and capsaicin in the rat. Pain 1995; 61: 317-23
-
(1995)
Pain
, vol.61
, pp. 317-323
-
-
Craft, R.M.1
Cohen, S.M.2
Porreca, F.3
-
9
-
-
0035724244
-
Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder
-
Yiangou Y, Facer P, Ford A et al. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int 2001; 87: 774-9
-
(2001)
BJU Int
, vol.87
, pp. 774-779
-
-
Yiangou, Y.1
Facer, P.2
Ford, A.3
-
10
-
-
0035818575
-
Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells
-
Birder LA, Kanai AJ, de Groat WC et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001; 98: 13396-401
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 13396-13401
-
-
Birder, L.A.1
Kanai, A.J.2
De Groat, W.C.3
-
11
-
-
13844294354
-
Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin
-
Apostolidis A, Brady CM, Yiangou Y, Davis J, Fowler CJ, Anand P. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Urology 2005; 65: 400-5
-
(2005)
Urology
, vol.65
, pp. 400-405
-
-
Apostolidis, A.1
Brady, C.M.2
Yiangou, Y.3
Davis, J.4
Fowler, C.J.5
Anand, P.6
-
12
-
-
0030777012
-
The capsaicin receptor: A heat-activated ion channel in the pain pathway
-
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-24
-
(1997)
Nature
, vol.389
, pp. 816-824
-
-
Caterina, M.J.1
Schumacher, M.A.2
Tominaga, M.3
Rosen, T.A.4
Levine, J.D.5
Julius, D.6
-
13
-
-
0034646740
-
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
-
Caterina MJ, Leffler A, Malmberg AB et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288: 306-13
-
(2000)
Science
, vol.288
, pp. 306-313
-
-
Caterina, M.J.1
Leffler, A.2
Malmberg, A.B.3
-
14
-
-
0036242533
-
Central pathways controlling micturition and urinary continence
-
Blok BF. Central pathways controlling micturition and urinary continence. Urology 2002; 59 (Suppl. 5): 13-7
-
(2002)
Urology
, vol.59
, Issue.5 SUPPL.
, pp. 13-17
-
-
Blok, B.F.1
-
15
-
-
0033918384
-
Vanilloids and the overactive bladder
-
De Ridder D, Baert L. Vanilloids and the overactive bladder. BJU Int 2000; 86: 172-80
-
(2000)
BJU Int
, vol.86
, pp. 172-180
-
-
De Ridder, D.1
Baert, L.2
-
16
-
-
0036241981
-
Bladder afferents and their role in the overactive bladder
-
Fowler CJ. Bladder afferents and their role in the overactive bladder. Urology 2002; 59 (Suppl. 5): 37-42
-
(2002)
Urology
, vol.59
, Issue.5 SUPPL.
, pp. 37-42
-
-
Fowler, C.J.1
-
17
-
-
0036728668
-
Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1
-
Birder LA, Nakamura Y, Kiss S et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002; 5: 856-60
-
(2002)
Nat Neurosci
, vol.5
, pp. 856-860
-
-
Birder, L.A.1
Nakamura, Y.2
Kiss, S.3
-
18
-
-
11144354574
-
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment
-
Brady CM, Apostolidis AN, Harper M et al. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int 2004; 93: 770-6
-
(2004)
BJU Int
, vol.93
, pp. 770-776
-
-
Brady, C.M.1
Apostolidis, A.N.2
Harper, M.3
-
19
-
-
0022644364
-
The role of the capsaicin-sensitive innervation of the rat urinary bladder in the activation of micturition reflex
-
Maggi CA, Santicioli P, Borsini F, Giuliani S, Meli A. The role of the capsaicin-sensitive innervation of the rat urinary bladder in the activation of micturition reflex. Naunyn Schmiedebergs Arch Pharmacol 1986; 332: 276-83
-
(1986)
Naunyn Schmiedebergs Arch Pharmacol
, vol.332
, pp. 276-283
-
-
Maggi, C.A.1
Santicioli, P.2
Borsini, F.3
Giuliani, S.4
Meli, A.5
-
20
-
-
0024324862
-
Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans
-
Maggi CA, Barbanti G, Santicioli P et al. Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 1989; 142: 150-4
-
(1989)
J Urol
, vol.142
, pp. 150-154
-
-
Maggi, C.A.1
Barbanti, G.2
Santicioli, P.3
-
21
-
-
0034185210
-
Intravesical treatment of overactive bladder
-
Fowler CJ. Intravesical treatment of overactive bladder. Urology 2000; 55 (Suppl. 5A): 60-4
-
(2000)
Urology
, vol.55
, Issue.SUPPL. 5A
, pp. 60-64
-
-
Fowler, C.J.1
-
23
-
-
0028009550
-
Intravesical capsaicin for treatment of detrusor hyperreflexia
-
Fowler CJ, Beck RO, Gerrard S, Betts CD, Fowler CG. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994; 57: 169-73
-
(1994)
J Neurol Neurosurg Psychiatry
, vol.57
, pp. 169-173
-
-
Fowler, C.J.1
Beck, R.O.2
Gerrard, S.3
Betts, C.D.4
Fowler, C.G.5
-
24
-
-
0028839276
-
Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia
-
Geirsson G, Fall M, Sullivan L. Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. J Urol 1995; 154: 1825-9
-
(1995)
J Urol
, vol.154
, pp. 1825-1829
-
-
Geirsson, G.1
Fall, M.2
Sullivan, L.3
-
25
-
-
18544405115
-
Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction
-
Cruz F, Guimaraes M, Silva C, Rio ME, Coimbra A, Reis M. Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 1997; 157: 585-9
-
(1997)
J Urol
, vol.157
, pp. 585-589
-
-
Cruz, F.1
Guimaraes, M.2
Silva, C.3
Rio, M.E.4
Coimbra, A.5
Reis, M.6
-
26
-
-
0030771639
-
Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: A dual center study with long-term followup
-
De Ridder D, Chandiramani V, Dasgupta P, Van Poppel H, Baert L, Fowler CJ. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol 1997; 158: 2087-92
-
(1997)
J Urol
, vol.158
, pp. 2087-2092
-
-
De Ridder, D.1
Chandiramani, V.2
Dasgupta, P.3
Van Poppel, H.4
Baert, L.5
Fowler, C.J.6
-
27
-
-
0031711858
-
Capsaicin and neurogenic detrusor hyperreflexia: A double-blind placebo-controlled study in 20 patients with spinal cord lesions
-
de Seze M, Wiart L, Joseph PA, Dosque JP, Mazaux JM, Barat M. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998; 17: 513-23
-
(1998)
Neurourol Urodyn
, vol.17
, pp. 513-523
-
-
De Seze, M.1
Wiart, L.2
Joseph, P.A.3
Dosque, J.P.4
Mazaux, J.M.5
Barat, M.6
-
28
-
-
6844236391
-
The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results
-
Wiart L, Joseph PA, Petit H et al. The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. Spinal Cord 1998; 36: 95-9
-
(1998)
Spinal Cord
, vol.36
, pp. 95-99
-
-
Wiart, L.1
Joseph, P.A.2
Petit, H.3
-
29
-
-
0036130526
-
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: A prospective randomized study
-
Giannantoni A, Di Stasi SM, Stephen RL et al. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 2002; 167: 1710-4
-
(2002)
J Urol
, vol.167
, pp. 1710-1714
-
-
Giannantoni, A.1
Di Stasi, S.M.2
Stephen, R.L.3
-
30
-
-
0036077240
-
The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input
-
Silva C, Ribeiro MJ, Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 2002; 168: 575-9
-
(2002)
J Urol
, vol.168
, pp. 575-579
-
-
Silva, C.1
Ribeiro, M.J.2
Cruz, F.3
-
31
-
-
0346848783
-
Intravesical resiniferatoxin for refractory detrusor hyperreflexia: A multicenter, blinded, randomized, placebo-controlled trial
-
Kim JH, Rivas DA, Shenot PJ et al. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med 2003; 26: 358-63
-
(2003)
J Spinal Cord Med
, vol.26
, pp. 358-363
-
-
Kim, J.H.1
Rivas, D.A.2
Shenot, P.J.3
-
32
-
-
0142092297
-
Effectiveness of intravesical resiniferatoxin in treating detrusor hyperreflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions
-
Kuo HC. Effectiveness of intravesical resiniferatoxin in treating detrusor hyperreflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions. BJU Int 2003; 92: 597-601
-
(2003)
BJU Int
, vol.92
, pp. 597-601
-
-
Kuo, H.C.1
-
33
-
-
0041737367
-
Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions
-
Kuo HC. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 2003; 170: 835-9
-
(2003)
J Urol
, vol.170
, pp. 835-839
-
-
Kuo, H.C.1
-
34
-
-
10744223250
-
Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: A double-blind, randomized, controlled study
-
de Seze M, Wiart L, de Seze MP et al. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. J Urol 2004; 171: 251-5
-
(2004)
J Urol
, vol.171
, pp. 251-255
-
-
De Seze, M.1
Wiart, L.2
De Seze, M.P.3
-
35
-
-
18544368188
-
Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics
-
Kuo HC. Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics. BJU Int 2005; 95: 1023-7
-
(2005)
BJU Int
, vol.95
, pp. 1023-1027
-
-
Kuo, H.C.1
-
36
-
-
24644449231
-
Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: Results of a double-blind randomized placebo-controlled trial
-
Silva C, Silva J, Ribeiro MJ, Avelino A, Cruz F. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial. Eur Urol 2005; 48: 650-5
-
(2005)
Eur Urol
, vol.48
, pp. 650-655
-
-
Silva, C.1
Silva, J.2
Ribeiro, M.J.3
Avelino, A.4
Cruz, F.5
-
37
-
-
3142616432
-
Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity
-
Yokoyama T, Nozaki K, Fujita O, Nose H, Inoue M, Kumon H. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity. J Urol 2004; 172: 596-600
-
(2004)
J Urol
, vol.172
, pp. 596-600
-
-
Yokoyama, T.1
Nozaki, K.2
Fujita, O.3
Nose, H.4
Inoue, M.5
Kumon, H.6
-
38
-
-
33746676066
-
The effect of bladder sensory input modulation on urgency: Data from a placebo- controlled trial with intravesical resiniferatoxin
-
Abstract 797
-
Silva C, Silva J, Castro H et al. The effect of bladder sensory input modulation on urgency: data from a placebo- controlled trial with intravesical resiniferatoxin. Eur Urol 2006; 5: 222, Abstract 797
-
(2006)
Eur Urol
, vol.5
, pp. 222
-
-
Silva, C.1
Silva, J.2
Castro, H.3
-
39
-
-
20244375697
-
Intravesical resiniferatoxin for the treatment of interstitial cystitis: A randomized, double-blind, placebo controlled trial
-
Payne CK, Mosbaugh PG, Forrest JB et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 2005; 173: 1590-4
-
(2005)
J Urol
, vol.173
, pp. 1590-1594
-
-
Payne, C.K.1
Mosbaugh, P.G.2
Forrest, J.B.3
-
40
-
-
0023909940
-
Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients
-
Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988; 139: 919-22
-
(1988)
J Urol
, vol.139
, pp. 919-922
-
-
Dykstra, D.D.1
Sidi, A.A.2
Scott, A.B.3
Pagel, J.M.4
Goldish, G.D.5
-
41
-
-
0000284609
-
Botulinum A-toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: A new alternative to medical and surgical procedures?
-
Stöhrer M, Schurch B, Kramer G et al. Botulinum A-toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures? Neurourol Urodyn 1999; 18: 401-2
-
(1999)
Neurourol Urodyn
, vol.18
, pp. 401-402
-
-
Stöhrer, M.1
Schurch, B.2
Kramer, G.3
-
42
-
-
0033870343
-
Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results
-
Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000; 164: 692-7
-
(2000)
J Urol
, vol.164
, pp. 692-697
-
-
Schurch, B.1
Stohrer, M.2
Kramer, G.3
Schmid, D.M.4
Gaul, G.5
Hauri, D.6
-
44
-
-
0002837246
-
Über einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus
-
Van Ermengem E. Über einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Ztsch Hyg Infekt 1897; 26: 1-56
-
(1897)
Ztsch Hyg Infekt
, vol.26
, pp. 1-56
-
-
Van Ermengem, E.1
-
45
-
-
0004045029
-
History and current applications of botulinum toxin - From poison to remedy
-
Oxford: Blackwell Science
-
Naumann M, Toyka KV, Moore P. History and current applications of botulinum toxin - from poison to remedy. In Handbook of Botulinum Toxin Treatment. Oxford: Blackwell Science, 2003: 3-8
-
(2003)
Handbook of Botulinum Toxin Treatment
, pp. 3-8
-
-
Naumann, M.1
Toyka, K.V.2
Moore, P.3
-
46
-
-
0019761968
-
Botulinum toxin injection of eye muscles to correct strabismus
-
Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981; 79: 734-70
-
(1981)
Trans Am Ophthalmol Soc
, vol.79
, pp. 734-770
-
-
Scott, A.B.1
-
47
-
-
0000810225
-
Botulinum toxin: Historical perspective and potential new indications
-
Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl 1997; 6: S129-45
-
(1997)
Muscle Nerve Suppl
, vol.6
-
-
Jankovic, J.1
Brin, M.F.2
-
48
-
-
33748271738
-
Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
-
Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 1997; 6: S146-68
-
(1997)
Muscle Nerve Suppl
, vol.6
-
-
Brin, M.F.1
-
49
-
-
0033055065
-
Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals
-
de Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci 1999; 96: 3200-5
-
(1999)
Proc Natl Acad Sci
, vol.96
, pp. 3200-3205
-
-
De Paiva, A.1
Meunier, F.A.2
Molgo, J.3
Aoki, K.R.4
Dolly, J.O.5
-
50
-
-
7944239707
-
Botulinum toxin has antinociceptive effects in treating interstitial cystitis
-
Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB. Botulinum toxin has antinociceptive effects in treating interstitial cystitis. Urology 2004; 64: 871-5
-
(2004)
Urology
, vol.64
, pp. 871-875
-
-
Smith, C.P.1
Radziszewski, P.2
Borkowski, A.3
Somogyi, G.T.4
Boone, T.B.5
Chancellor, M.B.6
-
51
-
-
33644860325
-
Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study
-
Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol 2006; 49: 704-9
-
(2006)
Eur Urol
, vol.49
, pp. 704-709
-
-
Giannantoni, A.1
Costantini, E.2
Di Stasi, S.M.3
Tascini, M.C.4
Bini, V.5
Porena, M.6
-
52
-
-
23944435889
-
Preliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis
-
Kuo HC. Preliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis. Urol Int 2005; 75: 170-4
-
(2005)
Urol Int
, vol.75
, pp. 170-174
-
-
Kuo, H.C.1
-
53
-
-
22344452083
-
Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: Urodynamic outcome and patient satisfaction
-
Schulte-Baukloh H, Weiss C, Stolze T, Sturzebecher B, Knispel HH. Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 2005; 66: 82-7
-
(2005)
Urology
, vol.66
, pp. 82-87
-
-
Schulte-Baukloh, H.1
Weiss, C.2
Stolze, T.3
Sturzebecher, B.4
Knispel, H.H.5
-
54
-
-
23744514242
-
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity
-
Apostolidis A, Popat R, Yiangou Y et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005; 174: 977-83
-
(2005)
J Urol
, vol.174
, pp. 977-983
-
-
Apostolidis, A.1
Popat, R.2
Yiangou, Y.3
-
55
-
-
4444289380
-
Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury
-
Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 2004; 45: 987-93
-
(2004)
Neurochem Int
, vol.45
, pp. 987-993
-
-
Khera, M.1
Somogyi, G.T.2
Kiss, S.3
Boone, T.B.4
Smith, C.P.5
-
56
-
-
4544372009
-
Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats
-
Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB. Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 2004; 172: 1529-32
-
(2004)
J Urol
, vol.172
, pp. 1529-1532
-
-
Chuang, Y.C.1
Yoshimura, N.2
Huang, C.C.3
Chiang, P.H.4
Chancellor, M.B.5
-
57
-
-
8444246390
-
Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder
-
Haferkamp A, Schurch B, Reitz A et al. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder. Eur Urol 2004; 46: 784-91
-
(2004)
Eur Urol
, vol.46
, pp. 784-791
-
-
Haferkamp, A.1
Schurch, B.2
Reitz, A.3
-
58
-
-
33746672988
-
Histological features in the urinary bladder wall affected by neurogenic overactivity, a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A
-
Comperat E, Reitz A, Delcourt A et al. Histological features in the urinary bladder wall affected by neurogenic overactivity, a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 2006; 5: 80, A229
-
(2006)
Eur Urol
, vol.5
, pp. 80
-
-
Comperat, E.1
Reitz, A.2
Delcourt, A.3
-
59
-
-
22844433307
-
Adverse events after botulinum A toxin injection for neurogenic voiding disorders
-
De Laet K, Wyndaele JJ. Adverse events after botulinum A toxin injection for neurogenic voiding disorders. Spinal Cord 2005; 43: 397-9
-
(2005)
Spinal Cord
, vol.43
, pp. 397-399
-
-
De Laet, K.1
Wyndaele, J.J.2
-
60
-
-
12144288856
-
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity
-
Reitz A, Stohrer M, Kramer G et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45: 510-5
-
(2004)
Eur Urol
, vol.45
, pp. 510-515
-
-
Reitz, A.1
Stohrer, M.2
Kramer, G.3
-
61
-
-
20444459051
-
Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: Results of a single treatment, randomized, placebo controlled 6-month study
-
Schurch B, de Seze M, Denys P et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005; 174: 196-200
-
(2005)
J Urol
, vol.174
, pp. 196-200
-
-
Schurch, B.1
De Seze, M.2
Denys, P.3
-
62
-
-
77949807634
-
Detrusor injections of botulinum toxin A in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections
-
Game X, Bentaleb Y, Thiry-Escudie I et al. Detrusor injections of botulinum toxin A in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 2006; 5: 229, A1107
-
(2006)
Eur Urol
, vol.5
, pp. 229
-
-
Game, X.1
Bentaleb, Y.2
Thiry-Escudie, I.3
-
63
-
-
17144372940
-
Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence
-
Grosse J, Kramer G, Stoehrer M. Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005; 47: 653-9
-
(2005)
Eur Urol
, vol.47
, pp. 653-659
-
-
Grosse, J.1
Kramer, G.2
Stoehrer, M.3
-
64
-
-
26644449458
-
Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity
-
Schulte-Baukloh H, Knispel HH, Stolze T et al. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 2005; 66: 865-70
-
(2005)
Urology
, vol.66
, pp. 865-870
-
-
Schulte-Baukloh, H.1
Knispel, H.H.2
Stolze, T.3
-
65
-
-
33746740860
-
Botulinum toxin type A as an alternative in the treatment of hyperactive bladder dysfunction: What do patients think?
-
Schulte-Baukloh H, Schobert J, Weiss C et al. Botulinum toxin type A as an alternative in the treatment of hyperactive bladder dysfunction: what do patients think? Urologe A 2003; 1: 42, A4.8
-
(2003)
Urologe A
, vol.1
, pp. 42
-
-
Schulte-Baukloh, H.1
Schobert, J.2
Weiss, C.3
-
66
-
-
1542333506
-
Successful use of bladder botulinum toxin injection to treat refractory overactive bladder
-
Abstract
-
Chancellor M, O'Leary M, Erickson J et al. Successful use of bladder botulinum toxin injection to treat refractory overactive bladder. J Urol 2003; 169: 351, Abstract
-
(2003)
J Urol
, vol.169
, pp. 351
-
-
Chancellor, M.1
O'Leary, M.2
Erickson, J.3
-
67
-
-
2942613330
-
Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: An initial experience
-
Rapp DE, Lucioni A, Katz EE, O'Connor RC, Gerber GS, Bales GT. Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 2004; 63: 1071-5
-
(2004)
Urology
, vol.63
, pp. 1071-1075
-
-
Rapp, D.E.1
Lucioni, A.2
Katz, E.E.3
O'Connor, R.C.4
Gerber, G.S.5
Bales, G.T.6
-
68
-
-
2342642136
-
Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents
-
Kuo HC. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 2004; 63: 868-72
-
(2004)
Urology
, vol.63
, pp. 868-872
-
-
Kuo, H.C.1
-
69
-
-
8644281254
-
The effect of botulinum-A toxin on patients with severe urge urinary incontinence
-
Flynn MK, Webster GD, Amundsen CL. The effect of botulinum-A toxin on patients with severe urge urinary incontinence. J Urol 2004; 172: 2316-20
-
(2004)
J Urol
, vol.172
, pp. 2316-2320
-
-
Flynn, M.K.1
Webster, G.D.2
Amundsen, C.L.3
-
70
-
-
18144368897
-
Botulinum A toxin injections into the detrusor: An effective treatment in idiopathic and neurogenic detrusor overactivity?
-
Kessler TM, Danuser H, Schumacher M, Studer UE, Burkhard FC. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 2005; 24: 231-6
-
(2005)
Neurourol Urodyn
, vol.24
, pp. 231-236
-
-
Kessler, T.M.1
Danuser, H.2
Schumacher, M.3
Studer, U.E.4
Burkhard, F.C.5
-
71
-
-
22344457486
-
Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics
-
Kuo HC. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology 2005; 66: 94-8
-
(2005)
Urology
, vol.66
, pp. 94-98
-
-
Kuo, H.C.1
-
72
-
-
27844538452
-
Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: Objective outcome and patient satisfaction
-
Schulte-Baukloh H, Weiss C, Stolze T et al. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 2005; 48: 984-90
-
(2005)
Eur Urol
, vol.48
, pp. 984-990
-
-
Schulte-Baukloh, H.1
Weiss, C.2
Stolze, T.3
-
73
-
-
12844268481
-
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra
-
Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 2005; 65: 37-41
-
(2005)
Urology
, vol.65
, pp. 37-41
-
-
Smith, C.P.1
Nishiguchi, J.2
O'Leary, M.3
Yoshimura, N.4
Chancellor, M.B.5
-
74
-
-
20644447123
-
Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: A prospective nonrandomized study
-
Werner M, Schmid DM, Schussler B. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol 2005; 192: 1735-40
-
(2005)
Am J Obstet Gynecol
, vol.192
, pp. 1735-1740
-
-
Werner, M.1
Schmid, D.M.2
Schussler, B.3
-
75
-
-
33746700578
-
Botulinum toxin A is safe and effective in the treatment of patients with overactive bladder and idiopathic detrusor overactivity: Results from a randomised, double-blind, placebo-controlled trial
-
Sahai A, Khan S, Dasgupta P. Botulinum toxin A is safe and effective in the treatment of patients with overactive bladder and idiopathic detrusor overactivity: results from a randomised, double-blind, placebo-controlled trial. Eur Urol 2006; 5: 118, A381
-
(2006)
Eur Urol
, vol.5
, pp. 118
-
-
Sahai, A.1
Khan, S.2
Dasgupta, P.3
-
76
-
-
1542303631
-
Pressure flow study: A useful diagnostic test of female lower urinary tract symptoms
-
Digesu GA, Hutchings A, Salvatore S, Selvaggi L, Milani R, Khullar V. Pressure flow study: a useful diagnostic test of female lower urinary tract symptoms. Neurourol Urodyn 2004; 23: 104-8
-
(2004)
Neurourol Urodyn
, vol.23
, pp. 104-108
-
-
Digesu, G.A.1
Hutchings, A.2
Salvatore, S.3
Selvaggi, L.4
Milani, R.5
Khullar, V.6
-
77
-
-
3242745240
-
Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: A prospective randomized study
-
Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol 2004; 172: 240-3
-
(2004)
J Urol
, vol.172
, pp. 240-243
-
-
Giannantoni, A.1
Di Stasi, S.M.2
Stephen, R.L.3
Bini, V.4
Costantini, E.5
Porena, M.6
-
78
-
-
23744463960
-
A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin
-
Popat R, Apostolidis A, Kalsi V, Gonzales G, Fowler CJ, Dasgupta P. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 2005; 174: 984-9
-
(2005)
J Urol
, vol.174
, pp. 984-989
-
-
Popat, R.1
Apostolidis, A.2
Kalsi, V.3
Gonzales, G.4
Fowler, C.J.5
Dasgupta, P.6
-
80
-
-
0347759835
-
Botulinum toxin type B for type A resistant bladder spasticity
-
Pistolesi D, Selli C, Rossi B, Stampacchia G. Botulinum toxin type B for type A resistant bladder spasticity. J Urol 2004; 171: 802-3
-
(2004)
J Urol
, vol.171
, pp. 802-803
-
-
Pistolesi, D.1
Selli, C.2
Rossi, B.3
Stampacchia, G.4
-
81
-
-
85048378627
-
Botulinum toxin type B injection for the management of type A resistant neurogenic detrusor overactivity
-
Reitz A, Schurch B. Botulinum toxin type B injection for the management of type A resistant neurogenic detrusor overactivity. J Urol 2004; 171: 804-5
-
(2004)
J Urol
, vol.171
, pp. 804-805
-
-
Reitz, A.1
Schurch, B.2
-
82
-
-
27544477692
-
Effects of botulinum toxin B on refractory detrusor overactivity: A randomized, double-blind, placebo controlled, crossover trial
-
Ghei M, Maraj BH, Miller R et al. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol 2005; 174: 1873-7
-
(2005)
J Urol
, vol.174
, pp. 1873-1877
-
-
Ghei, M.1
Maraj, B.H.2
Miller, R.3
|